Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: The HERO study

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 6, 2000, Pages 751-758

  Katelaris, P H ^a,g   Adamthwaite, D ^b   Midolo, P ^c   Yeomans, N D ^d   Davidson, G ^e   Lambert, J ^f  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b ST JOHN OF GOD HOSPITAL   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d WESTERN HOSPITAL   (Australia)

^e WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^f PENINSULA HEALTH   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; UREA;

ABDOMINAL PAIN; ADULT; ARTICLE; AUSTRALIA AND NEW ZEALAND; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; DUODENUM ULCER; DYSPEPSIA; ERADICATION THERAPY; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HEADACHE; HEARTBURN; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; TREATMENT OUTCOME;

EID: 0034079471     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00776.x     Document Type: Article

References (24)

1. 1 Lind T, Megraud F, Unge P, et al. The MACH 2 Study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999; 116: 248-53.
2. 2 Katelaris PH, Nguyen TV, Robertson G, Bradbury R, Ngu MC. Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients. Aust NZ J Med 1998; 28: 635-8.
3. 3 Xia HH, Kalantar J, Talley NJ. Metronidazole-and darithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sites. J Gastroenterol Hepatol 1998; 13: 1044-9.
4. 4 Ching CK, Leung KP, Yung RW, et al. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut 1996; 38: 675-8.
5. 5 Banatvala N, Davies GR, Abdi Y, et al. High prevalence of Helicobacter Pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 1994; 5: 1562-6.
6. 6 European Study Group on Antibiotic Susceptibility of Helicobacter pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 777-81.
7. 7 Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 1993; 86: 743-50.
8. 8 Bell GD, Powell KU, Burridge SM, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 41-6.
9. 9 Bardhan KD, Bayerdoffer E, Delchier JP, et al. H. pylori eradication with omeprazole, metronidazole and clarithromycin: the impact of drug dosing and resistance on efficacy: The HOMER story. Gastroenterology 1998; 114: A65(Abstract).
10. 10 Bayerdorffer E, Lonovics J, Dite P, et al. The efficacy of two dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter Pylori infection: The HERA Study. Gastroenterology 1998; 114: A69(Abstract).
11. 11 Lind T, van Zanten Veldhuyzen S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter 1996; 1: 138-44.
12. 12 Malfertheiner P, Bayerdorffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 1999; 15: 703-12.
13. 13 Veldhuyzen SJO, Bradette M, Parley A, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13: 289-95.
14. 14 Forbes GM, Collins BJ, McCullough CA, Coombs GW, Robins PD. Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance. Aust NZ J Med 1998; 28: 13-7.
15. 15 Henry A, Batey RG. Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study. Am J Gastroenterol 1999; 94: 811-5.
16. 16 Katelaris PH, Nguyen TV, Robertson G, Ngu MC. Proton pump inhibitor triple therapies for Helicobacter pylori in clinical practice: the impact of clarithromycin and the 'cost' of metronidazole resistance. J Gastroenterol Hepatology 1998; 13(Suppl.): A187(Abstract).
17. 17 Misiewicz JJ, Harris AW, Bardhan KD, et al. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Gut 1997; 41: 735-9.
18. 13C-urea breath test. Am J Gastroenterol 1993; 88: 1865-9.
19. 13C-urea breath test in Helicobacter pylori diagnosis and eradication. Scand J Gastroenterol 1997; 32: 308-14.
20. 13C-urea breath test. Gastroenterology 1996; 110: A144(Abstract).
21. 21 The European Helicobacter pylori Study Group. Current European concepts on the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8-13.
22. 22 Australian Gastroenterology Institute. Helicobacter pylori: Guidelines for Healthcare Workers, 3rd edn. Sydney, Australia: Gastroenterological Society of Australia, 1999.
23. 23 Katelaris PH, Nguyen TV, Robertson G. Efficacy of repeat treatments after initial failure of Helicobacter pylori eradication therapy. Gastroenterology 1999; 116: A205 (Abstract).
24. 24 Lee JM, Breslin NP, Hyde DK, Buckley MJ, O'Morain CA. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharmacol Ther 1999; 13: 489-96.